Oncogenic Mutations and Dysregulated Pathways in Obesity-Associated Hepatocellular Carcinoma

Oncogene - United Kingdom
doi 10.1038/onc.2016.162
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

K-Ras Mutation Subtypes in NSCLC and Associated Co-Occuring Mutations in Other Oncogenic Pathways

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells

PLoS ONE
Multidisciplinary
2016English

Oncogenic Wnt3a: A Promising Specific Biomarker in Hepatocellular Carcinoma

Hepatoma Research
2018English

Obesity Independently Drives NASH and Hepatocellular Carcinoma

Cancer Discovery
Oncology
2018English

WNT Status-Dependent Oncogenic Role of BCL9 and BCL9L in Hepatocellular Carcinoma

Hepatology International
Hepatology
2019English

Oncogenic Function and Prognostic Significance of Abelson Interactor 1 in Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2017English

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma

Journal of the American College of Surgeons
Surgery
2015English

CDK8 and CDK19 Kinases Have Non-Redundant Oncogenic Functions in Hepatocellular Carcinoma

2019English

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma

Frontiers in Genetics
GeneticsMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy